Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA)

Q: What does CUSIP 046513107 represent in this 13F holders report?

CUSIP 046513107 is the security identifier for ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in Q3 2022?

149 institutional investors reported ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share for Q3 2022. Use the holders table for investor-level position and value details.

CUSIP: 046513107

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 9,606,000
Total 13F shares: 97,668,961
Share change: -489,494
Total reported value: $369,193,024
Price per share: $3.78
Number of holders: 149
Value change: -$18,917,474
Number of buys: 97
Number of sells: 47

Quarterly Holders Quick Answers

What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 046513107:

Q1 2026 Q4 2025 Q3 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
JPMORGAN CHASE & CO	13F	Company	92%	8,861,252	$69,029,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	91%	8,764,706	$68,279,000	—	30 Jun 2022	13F
BAUPOST GROUP LLC/MA	13F	Company	85%	8,123,616	$63,283,000	—	30 Jun 2022	13F
MAVERICK CAPITAL LTD	13F	Company	82%	7,855,824	$61,197,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	76%	7,298,073	$56,852,000	—	30 Jun 2022	13F
Redmile Group, LLC	13F	Company	65%	6,242,756	$48,631,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	65%	6,221,686	$48,467,000	—	30 Jun 2022	13F
FMR LLC	13F	Company	61%	5,846,060	$45,541,000	—	30 Jun 2022	13F
WASATCH ADVISORS LP	13F	Company	53%	5,126,723	$39,937,000	—	30 Jun 2022	13F
Point72 Asset Management, L.P.	13F	Company	40%	3,877,200	$30,203,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	34%	3,223,884	$25,114,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	31%	2,938,296	$22,890,000	—	30 Jun 2022	13F
683 Capital Management, LLC	13F	Company	21%	2,045,000	$15,930,000	—	30 Jun 2022	13F
KPCB XV Associates, LLC	13F	Company	20%	1,876,650	$14,619,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	18%	1,711,450	$13,332,000	—	30 Jun 2022	13F
EMINENCE CAPITAL, LP	13F	Company	14%	1,323,075	$10,307,000	—	30 Jun 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	12%	1,144,956	$8,917,000	—	30 Jun 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	11%	1,080,565	$8,418,000	—	30 Jun 2022	13F
CITIGROUP INC	13F	Company	11%	1,033,544	$8,051,000	—	30 Jun 2022	13F
Antipodean Advisors LLC	13F	Company	10%	1,000,000	$7,790,000	—	30 Jun 2022	13F
Artal Group S.A.	13F	Company	10%	1,000,000	$7,790,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	9%	868,005	$6,761,000	—	30 Jun 2022	13F
NORGES BANK	13F	Company	8.3%	799,758	$6,230,115	—	30 Jun 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	7.7%	744,186	$5,797,000	—	30 Jun 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	7%	668,205	$5,205,000	—	30 Jun 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	7%	668,042	$5,205,000	—	30 Jun 2022	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	6.4%	616,900	$4,806,000	—	30 Jun 2022	13F
Assenagon Asset Management S.A.	13F	Company	6.3%	606,269	$4,723,000	—	30 Jun 2022	13F
PACIFIC HEIGHTS ASSET MANAGEMENT LLC	13F	Company	5.5%	525,000	$4,090,000	—	30 Jun 2022	13F
Nuveen Asset Management, LLC	13F	Company	5.4%	521,426	$4,062,000	—	30 Jun 2022	13F
PINNACLE ASSOCIATES LTD	13F	Company	4.5%	428,707	$3,340,000	—	30 Jun 2022	13F
STALEY CAPITAL ADVISERS INC	13F	Company	4.4%	425,000	$3,311,000	—	30 Jun 2022	13F
Rafferty Asset Management, LLC	13F	Company	4%	387,937	$3,022,000	—	30 Jun 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	3.6%	346,429	$2,699,000	—	30 Jun 2022	13F
Alberta Investment Management Corp	13F	Company	3.3%	318,430	$2,481,000	—	30 Jun 2022	13F
One Fin Capital Management LP	13F	Company	3.2%	303,000	$2,360,000	—	30 Jun 2022	13F
Bank of New York Mellon Corp	13F	Company	3.1%	294,897	$2,297,000	—	30 Jun 2022	13F
M28 Capital Management LP	13F	Company	2.8%	269,253	$2,097,000	—	30 Jun 2022	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	2.4%	228,532	$1,780,000	—	30 Jun 2022	13F
Ensign Peak Advisors, Inc	13F	Company	2.4%	227,527	$1,772,000	—	30 Jun 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.3%	225,200	$1,754,000	—	30 Jun 2022	13F
Integral Health Asset Management, LLC	13F	Company	2.2%	208,738	$1,626,000	—	30 Jun 2022	13F
Swiss National Bank	13F	Company	1.9%	186,400	$1,452,000	—	30 Jun 2022	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	1.7%	158,723	$1,236,000	—	30 Jun 2022	13F
BANK OF MONTREAL /CAN/	13F	Company	1.6%	153,799	$1,095,000	—	30 Jun 2022	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	1.5%	139,477	$1,087,000	—	30 Jun 2022	13F
RHUMBLINE ADVISERS	13F	Company	1.4%	139,185	$1,084,000	—	30 Jun 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	1.3%	126,489	$985,000	—	30 Jun 2022	13F
Gamma As Sector	13F	Individual	1.3%	123,713	$964,000	—	30 Jun 2022	13F
Trellus Management Company, LLC	13F	Company	1.1%	110,000	$857,000	—	30 Jun 2022	13F

Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA) as of Q3 2022

As of 30 Sep 2022, Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA) was held by 149 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 97,668,961 shares. The largest 10 holders included BlackRock Inc., JPMORGAN CHASE & CO, WASATCH ADVISORS INC, BAUPOST GROUP LLC/MA, STATE STREET CORP, MAVERICK CAPITAL LTD, VANGUARD GROUP INC, Redmile Group, LLC, GOLDMAN SACHS GROUP INC, and MORGAN STANLEY. This page lists 149 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

132

Q3 2022 holders

149

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.